Clinical Trials on Metastatic Prostate Adenocarcinoma in Finland
Total 699 results
-
Rahul AggarwalNovartisCompletedProstate CancerUnited States
-
Orion Corporation, Orion PharmaCompletedProstate CancerUnited States, United Kingdom, Finland, France, Estonia, Czech Republic
-
Helsinki University Central HospitalKarolinska InstitutetRecruitingKidney Cancer | Urothelial Carcinoma | Prostate Carcinoma | Penile Cancer | Testicular CancerFinland
-
Ferring PharmaceuticalsCompletedProstate CancerFinland, Belgium, Netherlands, Russian Federation, Germany, Romania, United Kingdom, France, Montenegro, Serbia
-
AmgenCompletedCarcinoma | Cancer | Prostate Cancer | Tumors | Castrate-Resistant Prostate CancerUnited States, Canada, Poland, Hungary, Finland, Mexico
-
Turku University HospitalUniversity of HelsinkiRecruitingHigh Grade Serous Carcinoma | High Grade Ovarian Serous AdenocarcinomaFinland
-
Ascenta TherapeuticsCompletedHormone Refractory Prostate CancerUnited States, Russian Federation
-
Astellas Pharma Global Development, Inc.Active, not recruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Spain, Taiwan, United Kingdom
-
University of HelsinkiCompletedBPH (Benign Prostatic Hyperplasia)Finland
-
AO Innovation Translation CenterAO Foundation, AO SpineRecruitingMetastatic Spine TumorUnited States, Canada, Hungary, Australia, Germany, Italy, Japan, Netherlands, Singapore, Switzerland
-
University of HelsinkiUniversity of Turku; Oulu University Hospital; Tampere University; South Ostrobothnia...CompletedBPH (Benign Prostatic Hyperplasia)Finland
-
Alessa Therapeutics Inc.CompletedLower Urinary Tract Symptoms | Prostate AdenocarcinomaUnited States, Australia, New Zealand
-
Dana-Farber Cancer InstituteAmbry GeneticsCompletedBreast Cancer | Pancreatic Cancer | Ovarian Cancer | Metastatic Prostate CancerUnited States
-
Tampere University HospitalCompletedProstatic Neoplasm | AnastomosisFinland
-
Novartis PharmaceuticalsActive, not recruitingMetastatic Pancreatic Ductal AdenocarcinomaUnited States, China, Hungary, Taiwan, Belgium, Germany, Spain, Italy, Czechia, France, Japan, Switzerland, Australia, Israel, Korea, Republic of, Canada, Russian Federation, Slovakia, United Kingdom, Turkey, Sweden, Greece, Finland, ... and more
-
European Organisation for Research and Treatment...TerminatedMetastatic CancerFrance, Finland, United Kingdom, Belgium, Israel, Germany, Switzerland, Netherlands, Turkey, Italy, Portugal, Spain, Latvia
-
US Oncology ResearchEli Lilly and Company; Oregon Health and Science UniversityCompletedAndrogen-independent Prostate CancerUnited States
-
US Oncology ResearchEli Lilly and Company; SanofiCompleted
-
University College, LondonRecruitingProstate CancerUnited States, Canada, Spain, Finland, Argentina, Australia, Belgium, Brazil, Denmark, France, Germany, Italy, Netherlands, Singapore, United Kingdom
-
Tampere University HospitalCompleted
-
Medi-Tate Ltd.CompletedBenign Prostate HyperplasiaUnited States, Canada
-
Brown UniversityThe Miriam HospitalCompletedProstate CancerUnited States
-
Uppsala UniversityRecruitingProstate CancerNorway, Denmark, Finland, Sweden, United Kingdom
-
University of HelsinkiActive, not recruitingBPH (Benign Prostatic Hyperplasia)Finland
-
Lawson Health Research InstituteVU University of Amsterdam; London Regional Cancer Program, CanadaActive, not recruitingMetastatic TumorsCanada, Australia, Netherlands, United Kingdom
-
Orion Corporation, Orion PharmaEndo PharmaceuticalsCompletedProstate CancerUnited States, United Kingdom, Finland, France, Czech Republic, Estonia
-
Sven LöffelerOslo University Hospital; KlinbeforskRecruitingProstate CancerNorway, Denmark, Finland
-
University of OuluOulu University HospitalTerminatedUrogenital Neoplasms | Neoplasms by Site | Genital Neoplasms, Male | Prostatic NeoplasmsFinland
-
University of OuluOulu University HospitalCompletedProstatic NeoplasmsFinland
-
Ferring PharmaceuticalsCompletedProstate CancerBelgium, Italy, Sweden, Portugal, Denmark, Finland, Norway, Turkey
-
University of Colorado, DenverBoston Scientific CorporationTerminated
-
Blue Earth DiagnosticsParexelCompletedProstate CancerUnited States, Finland, Germany, Netherlands
-
Bristol-Myers SquibbCompleted
-
DendreonCompletedProstatic Neoplasms | Advanced Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of California, Los Angeles; Ferring Pharmaceuticals; Wayne State University and other collaboratorsCompleted
-
GlaxoSmithKlineCompletedNeoplasms, ProstateUnited States, Australia, France, Germany, Spain, Bulgaria, Estonia, Italy, Poland, Netherlands, Belgium, United Kingdom, Canada, Denmark, Ukraine, Finland, Latvia, Russian Federation, Greece, Slovenia, Brazil, Mexico, Slovakia, Japan, Puerto... and more
-
DendreonPRA Health SciencesActive, not recruitingAdenocarcinoma of the ProstateUnited States
-
Steba Biotech S.A.ICON plc; International Drug Development InstituteCompletedCancer of the ProstateNetherlands, Spain, France, Germany, United Kingdom, Finland, Italy, Sweden
-
Ascenta TherapeuticsCompletedProstate CancerUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedPain | Breast Cancer | Lung Cancer | Prostate Cancer | Metastatic CancerUnited States
-
Steba Biotech S.A.CompletedProstate CancerSpain, France, Germany, Netherlands, United Kingdom, Belgium, Finland, Italy, Sweden, Switzerland
-
Ferring PharmaceuticalsCompletedProstate CancerDenmark, Sweden, Finland, Hungary, Norway, Romania, Russian Federation
-
AgennixCompletedProstate Cancer | Hormone Refractory Prostate CancerUnited States, United Kingdom, France, Italy, Israel, Germany, Hungary, Argentina, Russian Federation, Belgium, Croatia, Netherlands, Peru, Poland, Spain
-
Nymox CorporationCompletedPhase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate)Benign Prostatic Hyperplasia (BPH) | Enlarged ProstateUnited States
-
Incyte CorporationTerminatedProstate CancerUnited States
-
American College of Radiology Imaging NetworkNational Cancer Institute (NCI)CompletedPain | Unspecified Adult Solid Tumor, Protocol Specific | Metastatic CancerUnited States
-
Antisoma ResearchCompletedProstate CancerUnited States
-
Astellas Pharma IncCompletedProstate CancerBelgium, France, Spain, Italy, Hungary, Russian Federation, Germany, Slovakia, Finland, Czech Republic
-
AgennixTerminatedProstate CancerUnited States
-
Pia OsterlundRecruitingMetastatic Colorectal CancerFinland